Bank of New York Mellon Corp - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,724
-84.6%
52,8500.0%0.00%
Q2 2023$63,156
+72.9%
52,8500.0%0.00%
Q1 2023$36,530
+1.8%
52,8500.0%0.00%
Q4 2022$35,885
-33.5%
52,8500.0%0.00%
Q3 2022$54,000
+45.9%
52,850
-3.9%
0.00%
Q2 2022$37,000
-84.8%
54,985
-81.1%
0.00%
Q1 2022$244,000
-48.6%
291,0900.0%0.00%
Q4 2021$475,000
-19.2%
291,090
+19.4%
0.00%
Q3 2021$588,000
+29.5%
243,891
+41.6%
0.00%
Q2 2021$454,000
+254.7%
172,254
+571.9%
0.00%
Q1 2021$128,000
+75.3%
25,638
-44.5%
0.00%
Q4 2020$73,00046,1890.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders